Structure Therapeutics, Inc. (GPCR)
40.84
-0.26
(-0.63%)
USD |
NASDAQ |
May 06, 16:00
41.00
+0.16
(+0.39%)
Pre-Market: 08:23
Structure Therapeutics SG&A Expense (TTM) : 61.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.56B |
| Viking Therapeutics, Inc. | 48.28M |
| Novo Nordisk A/S | 10.66B |
| Revolution Medicines, Inc. | 195.04M |
| Kymera Therapeutics, Inc. | 72.27M |